In this week’s episode of the Talking Tech Transfer podcast we chat with Adam Stoten, the chief operating officer of Oxford University Innovation, about vaccines – not just for covid but also one for tuberculosis he helped develop at a spinout – as well as the importance of REF, KEF and the Knowledge Exchange Concordat, and the success of LAB282. He also exclusively reveals what is next for him personally.
 |
 |
 |
 |
 |
 |
 |
 |
 |
Regrowing limbs and a cure for leukaemia found at the bottom of the ocean are more science than fiction thanks to these companies
Global University Venturing is a quarterly magazine and website written for and about universities taking stakes in the spinout companies of staff and students. We help universities to share best practice and to connect with each other, with investors and with other useful parties in the innovation ecosystem. Our aim is to help improve the processes of bringing innovations from academia to the market and facilitate their integration into the business ecosystem.
